Skip to main content

Advertisement

Log in

The Application of a Safe Neutralization Assay for Ebola Virus Using Lentivirus-Based Pseudotyped Virus

  • LETTER
  • Published:
Virologica Sinica

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  • Chen Q, Tang K, Zhang X, Chen P, Guo Y (2018) Establishment of pseudovirus infection mouse models for in vivo pharmacodynamics evaluation of filovirus entry inhibitors. Acta Pharmaceutica Sinica B 8:200–208

    Article  Google Scholar 

  • Panina AA, Dementieva IG, Aliev TK, Toporova VA, Balabashin DS, Bokov MN, Pozdnyakova LP, Shchemchukova OB, Dolgikh DA, Sveshnikov PG, Kirpichnikov MP (2017) Recombinant Antibodies to the Ebola Virus Glycoprotein. Acta Naturae 9:84–91

    Article  CAS  Google Scholar 

  • Qiu C, Huang Y, Zhang A, Tian D, Wan Y, Zhang X, Zhang W, Zhang Z, Yuan Z, Hu Y (2013) Safe Pseudovirus-based Assay for Neutralization Antibodies against Influenza A(H7N9) Virus. Emerg Infect Dis 19:1685–1687

    PubMed  PubMed Central  Google Scholar 

  • Zhao G, Du L, Ma C, Li Y, Li L, Poon VK, Wang L, Yu F, Zheng BJ, Jiang S, Zhou Y (2013a) A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV. Virol J 10:266

    Article  Google Scholar 

  • Zhao GY, Du LY, Ma CQ, Li Y, Li L, Poon VKM, Wang LL, Yu F, Zheng BJ, Jiang SB, Zhou YS (2013b) A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV. Virol J 10(1):1–8

    Article  CAS  Google Scholar 

  • Zheng X, Wong G, Zhao Y, Wang H, He S, Bi Y, Chen W, Jin H, Gai W, Chu D, Cao Z, Wang C, Fan Q, Chi H, Gao Y, Wang T, Feng N, Yan F, Huang G, Zheng Y, Li N, Li Y, Qian J, Zou Y, Kobinger G, Gao GF, Qiu X, Yang S, Xia X (2016) Treatment with hyperimmune equine immunoglobulin or immunoglobulin fragments completely protects rodents from Ebola virus infection. Sci Rep 6:24179

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Gary Wong for help with experiments involving authentic EBOV. We thank our lab members and colleagues at Jilin University for helpful discussions during the course of the study. This research was supported by the National Science and Technology Major Project of the Ministry of Science and Technology of China (Grant 2016ZX10004222).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hualei Wang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Animal and Human Rights Statement

All animal studies in this work were approved by the Animal Care and Use Committee of the Chinese People’s Liberation Army (No. SYXK2009-045). All efforts were made to minimize animal suffering.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 150 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cao, Z., Jin, H., Wong, G. et al. The Application of a Safe Neutralization Assay for Ebola Virus Using Lentivirus-Based Pseudotyped Virus. Virol. Sin. 36, 1648–1651 (2021). https://doi.org/10.1007/s12250-021-00405-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12250-021-00405-8

Navigation